Skip to main content Skip to footer

In the News

Baylor Scott & White Heart and Vascular Hospital

Recent news

 

Wearing face masks while exercising reduces oxygen and increases heart rate

The result of a six-month study on the physiological effects of wearing a mask while working out during the COVID-19 pandemic showed wearing a face mask while exercising has a significant impact on the body. Researchers recorded vital signs and other data while the thirty-one participants ran on treadmills with and without cloth face coverings. The study found less oxygen in the blood and an increased heart rate among those wearing masks. The researchers say the study did not find exercising with a face mask was dangerous.

Watch the story


First in Fort Worth for treatment of severely calcified coronary artery plaques

Farhan Ali, MD, MA, MPH, FACC, FSCAI, RPVI, medical director for interventional cardiology for Baylor Scott & White Heart and Vascular Hospital - Fort Worth, announces that the first Shockwave Coronary IVL System in Fort Worth occurred in the hospital’s cath lab the week of April 6, 2021. Shockwave Coronary IVL System is a new innovative technology for the treatment of cardiac patients. Shockwave Coronary IVL (short for Intravascular Lithotripsy) was recently approved by the FDA for the treatment of severely calcified coronary artery plaques. The device uses a balloon to deliver sonic pressure waves that can pass through soft arterial tissue to “preferentially disrupt” calcified plaque and optimize stent placement. “This new technology allows for a possible safer way to deliver stents in heavily calcified arteries that in the past would have limited options for treatment,” says Dr. Ali. “We are proud to bring another ‘first’ to Fort Worth as a part of our advanced cardiovascular care program.”

An article was published a few months ago in the Journal of the American College of Cardiology (JACC) cites that patients with an advanced form of coronary artery disease (CAD) benefited from treatment that used sonic pressure waves to break up hardened blockages in the heart. The novel therapy is similar to the therapy used to break up kidney stones, and is known as Intravascular Lithotripsy (or IVL). Now that this is commercially available, more patients with cardiovascular disease will have this innovative procedure as a treatment option.

Read the article


Chief Medical Officer featured on Doing it Right! podcast

Kevin Wheelan, MD, FACC, Chief Medical Officer at Baylor Scott & White Heart and Vascular Hospital, is featured on a recent episode of Valerie Sokolosky's podcast, Doing it Right!. Now that the COVID-19 vaccine is becoming increasingly more available to segments of the population, Dr. Wheelan answers questions related to the vaccine, including why to get the vaccine, the difference between the various vaccines and effectiveness.

Listen to the podcast


How to exercise for heart health at home

In the era of COVID-19, many people face new challenges in remaining active. It is well known that exercise and an active lifestyle greatly reduces risk factors for and risk of developing cardiovascular disease, the No. 1 cause of death in the US. However, many traditional methods of exercise are now inaccessible (gyms, sporting groups, cardiac rehabilitations, etc.). Check out our resources, recommendations and information from the experts at cardiac rehabilitation to help keep you moving toward a healthy heart.

Learn more


Celebrating Cardiac Rehabilitation Week

Doug and Judy Laing have been attending Carter Cardiac and Pulmonary Rehabilitation for their heart and lung conditions. When a Texas snow storm postponed the celebrations planned for Cardiac Rehabilitation Week, the couple surprised the staff members and other rehab patients with their head-to-toe outfits! The nationally-celebrated week highlights the role of cardiac rehabilition in reducing the effects of heart disease. After a week of cold temps, this couple brought some much-needed warmth to everyone's heart.

Located on the campus of Baylor Scott & White All Saints Medical Center - Fort Worth, the Carter Rehabilitation Center's activity sessions are designed to meet our patient's personal needs, interests, and abilities. As an AACVPR-certified program, we are recognized as a cardiovascular and pulmonary rehabilitation leader, offering the most advanced practices available.

Learn more


North Texas man still dealing with lung damage one year after contracting COVID-19

A COVID-19 patient contracted the virus early on in March of 2020, among the first in North Texas. The virus severely impacted his lungs making it hard to do even simple daily chores like showering. He was referred to Baylor Scott & White All Saints Medical Center – Fort Worth, Carter Pulmonary and Cardiac Rehabilitation where he has completed the therapy and now back to living life. Before therapy, he could barely walk 50 feet, now he walks several miles per day without oxygen.

Watch his story


How quintuple bypass surgery changed my outlook on life

When Kenneth Hersh woke up on Tuesday, Oct. 6, 2020, little did he know that his life was about to take a major detour. The pain in his chest was mild, but the heaviness in his chest was more pronounced. Kenneth's arteries were 70 to 80% blocked and stents were not a treatment option. He had a quintuple coronary bypass graft operation.

Read his story


Cath lab team celebrates two Texas "firsts" in one day

On Monday, February 22, the catheterization lab team led by Robert Stoler, MD, FACC, FSCAI, co-medical director of cardiology and medical director for catheterization laboratory at Baylor Scott & White Heart and Vascular Hospital – Dallas, became the first in Texas to commercially use the Shockwave IVL System to treat severely calcified coronary arteries. Additionally, in a separate procedure, the team was the first in Texas to place SYNERGY MEGATRON™ from Boston Scientific Corporation, the first and only commercially available, purpose-built drug-eluting stent for large, proximal vessels. Both of these new procedures and the technology were approved by the Food & Drug Administration (FDA) recently. In addition, these new-to-market treatment options had clinical trials conducted on the campus of Baylor Scott & White Heart and Vascular Hospital – Dallas with Dr. Stoler as the principal investigator.

Learn more


Go Red for women and heart health

When Nancy Gopez had a heart attack, she recognized the symptoms from an American Heart Association event and immediately sought care. She is now an advocate for women’s heart health. Ravi Vallabhan, MD, a cardiologist on the medical staff at Baylor Scott & White Heart and Vascular Hospital – Dallas, explains how women can exhibit different symptoms than men.

Watch her story


Baylor Scott & White Heart and Vascular Hospital – Dallas Recognized for Cardiac and Patient Safety Excellence

Baylor Scott & White Heart and Vascular Hospital – Dallas achieves the Healthgrades Coronary Intervention Excellence Award™ for our second consecutive year and the 2020 Patient Safety Excellence Award™! This distinction places Baylor Scott & White Heart and Vascular Hospital – Dallas among our Nation’s top 10% of hospitals evaluated by Healthgrades, the leading resource that connects consumers, physicians and health systems. Baylor Scott & White Heart and Vascular – Dallas also received 5-Stars for Coronary Interventional Procedures, Treatment of Heart Attack and Pacemaker Procedures for the second consecutive year.

Visit Healthgrades


Dallas surgeons save woman's life after COVID-19 causes heart failure

A San Antonio woman who nearly died of COVID-19 credits Baylor University Medical Center's extracorporeal membrane oxygenation (ECMO) team for saving her life. Baylor Dallas' ECMO team has established safety protocols to treat COVID-19 patients. To date, the team has treated 50 COVID-19 patients using ECMO.

Watch her story


Dallas heart transplant recipient meets the family whose son saved his life

Kennedy Ngungutau was only 24 when he received his new heart and a second chance at life. Inspired by his experience, Kennedy wanted to give back to other heart patients. He began volunteering at Baylor Scott & White Heart and Vascular Hospital - Dallas in March 2020 and in October, he became an employee at the hospital. Impressed by his outlook on life and newly-found career path, the heart donor's family knew they needed to meet the man with their son's heart.

Watch the emotional experience


Dallas cardiologists play critical role in determining how sonic waves may help treat advanced heart disease

Research for a new treatment for coronary artery disease that included participation by cardiologists on the medical staff at Baylor Scott & White Heart and Vascular Hospital – Dallas (BSWHVH) was recently published in the October 2020 Journal of the American College of Cardiology (JACC). The article cites that patients with an advanced form of coronary artery disease benefited from an investigational treatment that used sonic pressure waves to break up hardened blockages in the heart. The novel therapy not yet available to the general public is similar to the therapy used to break up kidney stones, and is known as Intravascular Lithotripsy (or IVL). It is currently being reviewed by the US FDA for potential pre-market approval in the United States under a “Breakthrough” designation. One of the primary investigators was Robert Stoler, MD, FACC, FSCAI, co‐medical director for cardiology and medical director for catheterization laboratory at BSWHVH – Dallas.

Read more


Biostatistician selected to Frontiers in Cardiovascular Medicine editorial board

Baylor Scott & White Heart and Vascular Institute’s Kristen Tecson, PhD, was recently selected to the editorial board of Frontiers in Cardiovascular Medicine. Dr. Tecson has 50+ peer reviewed publications and her recognition as a cardiovascular biostatistician at Baylor Scott & White over the past five years has received worldwide acclaim. She will be responsible for assessing the rigor and validity of research and work collaboratively with authors and editors to improve manuscripts, ensuring only high-quality content is published in Frontiers in Cardiovascular Medicine. This journal places "an emphasis on studies that challenge the status quo of treatments and practices in cardiovascular care,” a great fit for Dr. Tecson’s talents.

Read more


Dallas heart transplant program reached 1,000 heart transplant patient milestone

Baylor University Medical Center reached another milestone in the program’s 35-year history. In September 2020, the team completed its 1,000th heart transplant since the program’s inception. This milestone could only be achieved with the involvement of a multidisciplinary team, including transplant cardiologists and surgeons on the medical staff, certified heart failure nurses, transplant coordinators, dietitians, social workers, and many more. The heart transplantation program at Baylor Dallas is the top heart transplant program in Texas and is one of the top 10 programs in the nation. Baylor Dallas was also recently selected as one of seven sites for the Carmat Total Artificial Heart, a landmark clinical trial and is the only site to offer the FDA-approved total artificial heart in the area.

Read more


Vascular surgeon inducted into American College of Surgeons Academy of Master Surgeon Educators™

John F. Eidt, MD, RVT, RPVI, FACS, a vascular surgeon from Dallas, TX, is among a group of 50 esteemed surgical educators inducted into membership in the American College of Surgeons (ACS) Academy of Master Surgeon Educators™ on September 25 at a Virtual Induction Ceremony. This is the third cohort of members inducted into this prestigious Academy.

Dr. Eidt was inducted as an Associate Member of this highly coveted Academy. He is the current vice chair of vascular surgery and a vascular surgeon on the medical staff at Baylor Scott & White Heart and Vascular Hospital – Dallas.

Read more


President and Chief Nursing Officer featured in Becker's Healthcare Podcast

Nancy Vish, RN, PhD, NEA-BC, President and Chief Nursing Officer at Baylor Scott & White Heart and Vascular Hospital in Dallas and Fort Worth, was featured on Becker's Healthcare Podcast discussing her advice for emerging leaders, the importance of strong values in leadership and more.

Becker's Healthcare Podcast is a new podcast from Becker's Healthcare, which features interviews and conversations with the latest in thought leadership in the healthcare industry.

Listen to the podcast


Surgeon sits on international panel discussing COVID-19: The View from ICU

Dan Meyer, MD, chief of heart transplantation and advanced circulatory support at Baylor University Medical Center, was one of three panelists who participated in a webinar hosted by The Australia Institute. "COVID-19: The View from ICU" is part of an international webinar series on the economics of a pandemic. Joining Dr. Meyer on the panel was Professor John Fraser, director of the critical care research group at the Prince Charles Hospital and University of Queensland, and Professor Carol Hodgson, deputy director at the Australian and NZ Intensive Care Research Centre.

The Australia Institute is one of the country’s most influential public policy think tanks. It conducts original research that contributes to a more just, sustainable and peaceful society. Based in Canberra, it conducts research on a broad range of economic, social, transparency and environmental issues in order to inform public debate and bring greater accountability to the democratic process.

Watch the webinar


Baylor Scott & White Research Institute hosts summer interns

The internship program at the Baylor Scott & White Research Institute provides an opportunity to work side-by-side with William C. Roberts, MD, MACC, a 60-year veteran in Cardiac Pathology, in an environment devoted exclusively to cardiac pathology research. This eight-week-long program offers a wide range of opportunities educating the interns (18 years and older) in the high global prevalence of cardiovascular disease, which remains the No. 1 cause of death worldwide. Students study the underlying causes of cardiovascular diseases through hands-on examination of specimens and through a variety of research. In doing so, they are able to produce fact-based editorials for publication. Students also participate in weekly cardiovascular conferences, attend cardiovascular specimen dictations and review histology sections for final diagnosis. Combined with working in a fast-paced office environment, their internship becomes one complete experience centered around the sciences, ethics and humanity.


Non-invasive team member earns national recognition

Baylor Scott & White Heart and Vascular Hospital’s Department of Non-Invasive Services announces the nationally recognized achievements by team member, Marie “Bunny” Owens, RDCS, RVT, who passed the American Society of Echocardiography board exam to become one of only 130 Advanced Cardiac Sonographers (ACS) in the US. She was also awarded the designation of Fellow – American Society of Echocardiography (FASE).

The ACS exam is the most difficult in the field of echocardiography for sonographers and demonstrates a profound knowledge and advanced level of critical thinking needed to perform advanced procedures. In some roles across the country, the ACS functions as an advanced practice sonographer, providing preliminary findings and interpretations to cardiologists.

The American Society of Echocardiography is a global organization with over 17,000 professional members, comprised of physicians, sonographers, nurses, veterinarians and scientists and sets the standards and guidelines we practice in the field of cardiovascular ultrasound today. Only those who have demonstrated an extraordinary commitment of education, research and volunteering earn this designation of FASE.


Hospital awarded Mission: Lifeline® / Get With The Guidelines Gold-Plus and Gold recognition

Announced in July 2020 by the American Heart Association, Baylor Scott & White Heart and Vascular Hospital – Dallas received Gold-Plus recognition as a STEMI Receiving Center and Gold for NSTEMI care. The 2020 Mission: Lifeline® awards acknowledge adherence to the GWTG®‐ Coronary Artery Disease quality performance standards from the analysis of 2019 registry data. Achieving Mission: Lifeline® Recognition denotes a commitment to high-quality systems of care among STEMI Receiving Centers, STEMI Referring Centers, 911 EMS agencies, interfacility transport agencies, and other supporting system participants through collaborative efforts, including quality improvement priorities outside the doors of your own facility.

The hospital received Mission: Lifeline® Gold Plus Receiving Quality Achievement Award for implementing specific quality improvement measures outlined by the American Heart Association for the treatment of patients who suffer severe heart attacks. The hospital earned the award by meeting specific criteria and standards of performance, including meeting 75% or greater compliance of the Quality PLUS measures, for quick and appropriate treatment through emergency procedures to re-establish blood flow to blocked arteries in heart attack patients coming into the hospital directly or by transfer from another facility. In addition, the Gold for NSTEMI care was awarded as a result of meeting specific criteria and standards of performance for the quick and appropriate treatment of NSTEMI heart attack patients by providing emergency procedures to re‐establish blood flow to blocked arteries when needed.

Interventional cardiology program


U.S. News & World Report 2020-21 rankings announced

U.S. News & World Report published its 2020‐2021 Best Hospitals list, and for the third consecutive year, Baylor Scott & White is the most award‐winning not‐for‐profit health system in Texas. Baylor Scott & White Heart and Vascular Hospital – Dallas was awarded High Performing in Abdominal Aortic Aneurysm Repair and Transcatheter Aortic Valve Replacement (TAVR). Baylor University Medical Center was awarded High Performing in the following cardiovascular categories: Aortic Valve Surgery, Congestive Heart Failure and Heart Bypass Surgery. Baylor Scott & White All Saints Medical Center ‐ Fort Worth received High Performing in Congestive Heart Failure as well as a regional ranking of #8 in the Dallas‐Fort Worth metroplex. Baylor University Medical Center received a regional ranking of #2 in the Dallas‐Fort Worth metroplex. Our legacy of providing quality, safe care has propelled us forward once again–even during one of the most challenging times in our history.

View all awards


First in Texas, second in nation to use new commercially-approved stent

The team at Baylor Scott & White Heart and Vascular Hospital - Dallas became the first in Texas and second site nationally to use a new 48mm stent to treat cardiovascular patients. This new-to-market stent features a fast-absorbing polymer for healing and reduces treatment costs in some cases where two stents were previously indicated.

Baylor Scott & White Heart and Vascular Hospital - Dallas was involved in the clinical trial "EVOLVE 48" which tested the efficacy of this stent. The hospital was the number one enrolling site worldwide for the trial.


Heart failure cardiologist finds promising results in COVID-19 clinical trial

Heart failure specialist on the medical staff, Robert Gottlieb, MD, is the co-principal investigator for the Baylor Scott & White Research Institute’s Dallas site to study the antiviral drug Remdesivir, collaborating with Gilead Sciences, to treat people who are severely ill with COVID-19. The Dallas site was one of 180 hospitals participating in the worldwide study fast-tracked during the height of the COVID-19 pandemic. Study results in June 2019 indicated that the drug helps shorten the illness time and the severity of the virus, decreasing morbidity by 62 percent. Furthermore, the study indicates that the drug provided over fewer days was as effective as providing dosing for ten days. At the time of printing, the results continue to be reviewed, but indications are promising.

Watch the story


Cardiologists lead trial studying use of hydroxychloroquine and treatment of COVID-19

Chief medical officer for Baylor Scott & White Heart and Vascular Hospital, Kevin Wheelan, MD, FACC, and the medical director for cardiovascular research and education for Baylor Scott & White Heart and Vascular Institute (Dallas), Peter McCullough, MD, MPH, FACC, FACP, FAHA, FCCP, FNKF, FNLA, FCRSA, were principal investigators in work on the Dallas campus related to the prophylactic use of hydroxyl in healthcare workers and antibody responses to COVID-19 in asymptomatic healthcare workers. They have championed outpatient treatment strategies at a national level advocating for patient care guidelines with the U.S. Food and Drug Administration and National Institutes of Health. Dr. McCullough has more than six publications on COVID-19 related work to date of this printing.


Fellow named to American Heart Association Science Subcommittee

Taimur Safder, MD, MPH, a third-year cardiology fellow, has been selected for the prestigious American Heart Association Science Subcommittee. Dr. Safder received his Bachelor’s Degree in biology and philosophy from Rockhurst University in Kansas City, MO and went on to receive his medical degree and complete his internal medicine residency at the University of Kansas School of Medicine in Kansas City, KS. He completed his Master’s in Public Health at the Harvard School of Public Health in Boston, MA. His scientific works have appeared in the New England Journal of Medicine and Journal of the American College of Cardiology. Dr. Safder joined the cardiology fellowship program in July 2018.


Vascular surgeon reaches milestone in innovative TCAR procedure

Bradley Grimsley, MD, vascular surgeon on the medical staff of Baylor Scott & White Heart and Vascular Hospital – Dallas, achieved a national and campus milestone by becoming one of the few surgeons in the United States to have reached the 200th procedure volume for Transcarotid Artery Revascularization or TCAR for short. The procedure is less invasive than open carotid endarterectomy and helps resolve blockages in the carotid artery that could lead to stroke.

Often performed under local anesthesia, a small incision is made just above a patient’s collar bone to expose the common carotid artery in the TCAR procedure. Then a soft, flexible sheath is placed directly into the carotid artery, connected to a specialized system to reverse the flow of blood away from the brain to protect against fragments of plaque that may come loose during the procedure. The blood is filtered and returned through a second sheath placed in the femoral vein in the patient’s thigh, and then the stent — a small wire mesh coil —is inserted and placed to open the artery.

Watch the video


Hospital President Nancy Vish provides guest commentary of DFW Hospital Council radio show

Nancy Vish, PhD, RN, NEA-BC, president and chief nursing officer for Baylor Scott & White Heart and Vascular Hospital, was featured on two segments of the Dallas Fort Worth Hospital Council’s The Human Side of Healthcare on KRLD Newsradio 1080 AM. The radio show and podcast series showcases healthcare leaders throughout the metroplex discussing all types of topics related to the business of healthcare, current topics and future trends. Moderated by DFW Hospital Council’s president and CEO, Stephen Love, the interview with Nancy Vish aired on May 26 and June 1, and the discussion included commentary on the unfortunate trend of people avoiding seeking urgent medical care for cardiac conditions due to COVID-19. The Baylor Scott & White COVID-19 Safe Care plan was explained.

Listen to the interview


Hispanic Cardiovascular Institute - Dallas hosts international webinar for physicians

The Hispanic Cardiovascular Institute - Dallas, in collaboration with Hospital Nacional Dos de Mayo, hosted a webinar for Peruvian physicians on the clinical management of critically ill adults with COVID-19. Moderated by Aldo Rafael, MD, a cardiac surgeon on the medical staff at Baylor University Medical Center, and Julio Peralta, MD, chief of thoracic and cardiovascular surgery at Dos de Mayo Hospital in Lima, Peru, the webinar shared lessons learned from the United States to assist Peruvian physicians in the care of COVID-19 positive patients.

Watch the webinar


Dr. Ossama Elsaid earns title of Best Teaching Fellow from Texas A&M College of Medicine

Texas A&M College of Medicine has awarded the Best Teaching Fellow this year to Ossama Elsaid, MD. This is a coveted distinction and is duly elected by the third and fourth-year medical students in recognition of the fellow who has exemplified the best attributes as a teacher and role model for future doctors. Dr. Elsaid received his MBBCh (MD equivalent) from Ain-Shams University School of Medicine, Cairo, Egypt, and served a preliminary internship year at Lincoln Medical Center, Weill Cornell Medical College, NY, before he came to Baylor University Medical Center and completed his internal medicine residency in 2013. He has worked for nearly five years as a cardiology hospitalist under the direction of Paul Thompson, MD, at Hartford Hospital, in Hartford CT (J-1 waiver satisfied). Dr. Elsaid joined the Baylor University Medical Center Cardiology Fellowship in July of 2018.


The Leapfrog Group announces “A” grade for hospital

Once again, Baylor Scott & White Heart and Vascular Hospital – Dallas received an ‘A’ in the spring 2020 Leapfrog Hospital Safety Grade, a national distinction recognizing achievements providing safer healthcare. This is the ninth consecutive “A” grade for the hospital. The Leapfrog Group is an independent national watchdog organization committed to healthcare quality and safety. The Safety Grade is a letter grade assigned to all general hospitals across the country and updated every six months, assessing how well the hospital prevents medical errors and other harms to patients. Baylor Scott & White Heart and Vascular Hospital – Dallas received an “A” for this time period for its commitment to reducing errors, infections, and accidents that can harm patients. Two times a year, the organization evaluates over 2,600 hospitals using national performance measures from the Centers for Medicare & Medicaid Services (CMS), the Leapfrog Hospital Survey and other data sources. The safety grades evaluate 28 measures of publicly available hospital safety data in process and structural measures and outcome measures.


Dallas campus cardiologist helps lead new clinical trial bringing potential COVID-19 treatments to North Texas

Robert Gottlieb, MD, heart transplant and heart failure cardiologist on the medical staff of Baylor Scott & White Heart and Vascular Hospital – Dallas and Baylor University Medical Center, is the principal investigator for a study launched through Baylor Scott & White Research Institute of an experimental treatment using the drug remdesivir in the fight against COVID-19. The Dallas campus study led by Dr. Gottlieb will be one of a few study sites nationwide. Additional details may be found in an article from Dallas Morning News published March 28, 2020.

Read the article


How to know if you have heart disease if you don't have symptoms

Heart disease may be advanced before you ever experience symptoms. Jeffrey Schussler, MD, interventional cardiologist on the medical staff at Baylor Scott & White Heart and Vascular Hospital – Dallas, discusses how to know if you have heart disease without symptoms and what tests you can take to know your risk for heart disease.

Listen to the interview


After a heart transplant, 24-year-old Kennedy Ngungutau is making every beat count

With a new heart and outlook on life, 24-year-old Kennedy Ngungutau is making every beat count! Inspired by his care as a patient, Kennedy is using his second chance at life to become a heart transplantation nurse and give patients just like him hope for recovery.

Watch the story


Finding your heart disease risk is as easy as pulling out your smartphone

David Lofthus, MD, a cardiologist on the medical staff at Baylor Scott & White Heart and Vascular Hospital – Dallas, chats with WFAA's Daybreak team to teach everyone how to assess their risk for cardiovascular disease on their smartphone.

Watch the story


Dallas woman saves husband twice using hands-only CPR

After her own cardiac event, Sandra Cheshier enrolled in Baylor Scott & White Heart and Vascular Hospital's Leap for Life class with her husband Pat. Learning hands-only CPR in class allowed Sandra to have her husband’s life twice in 2019 when he went into cardiac arrest at home. Together, they are looking forward to celebrating 50 years of marriage in June 2020.

Watch the story


Latest generation device available to treat ongoing cardiogenic shock

Chief of Transplant Cardiology, Mechanical Circulatory Support and Heart Failure, Dr. Shelley Hall, and vascular surgeon on the medical staff, Dr. Brad Grimsley, were the first in North Texas and the second team in Texas to implant this new device, Impella 5.5™ with SmartAssist®. This Impella 5.5 with Smart Assist is used in conjunction with the Automated Impella Controller™ and is collectively known as "Impella® System Therapy.” This is a temporary ventricular support device intended for short term use and is indicated for the treatment of ongoing cardiogenic shock that occurs immediately, defined as under 48 hours, following acute myocardial infarction or open-heart surgery or in the setting of cardiomyopathy, including peripartum cardiomyopathy, or myocarditis as a result of isolated left ventricular failure that is not responsive to optimal medical management and conventional treatment measures, including volume loading and use of pressors and inotropes, with or without IABP. The intent of Impella System Therapy is to reduce ventricular work and to provide the circulatory support necessary to allow heart recovery and early assessment of residual myocardial function.


Women at risk of high blood pressure at younger age than men

New research has found that women experience earlier and sharper rises in blood pressure than men. Dr. Fahmi Farah, a cardiologist on the medical staff at Baylor Scott & White Heart and Vascular Hospital – Fort Worth, chatted with NBC Channel 5 about the findings.

Watch the story


Nancy Vish, PhD, RN, NEA-BC, featured on Doing It Right Podcast

Nancy Vish, President and Chief Nursing Officer at Baylor Scott & White Heart and Vascular Hospital in both Dallas and Fort Worth, sits down with Valerie Sokolosky, host of the podcast Doing It Right, to discuss organizational culture, leadership and building a strong team.

Watch the podcast


ISCHEMIA study reveals some patients may not require stent placement

Fahmi Farah, MD, a cardiologist on the medical staff at Baylor Scott & White Heart and Vascular Hospital - Fort Worth, sat down with KERA's Vital Signs host, Sam Baker, to discuss the ISCHEMIA study. This new study suggests that alternative therapies may be available for certain patients who traditionally needed a stent.

Listen to the interview


29-year-old LVAD patient's hard work brings her heart back to life

At just 29 years old, Heather suffered a massive heart attack and required an LVAD to keep her heart working until she could receive a transplant. Through cardiac rehab and exercises, Heather's heart got stronger and she began to heal. One year later, she defeated the odds and became part of the 1% of LVAD patients in the country who get the device removed.

Watch her story


Cardiac surgery program earns highest rating from Society of Thoracic Surgeons

The cardiac surgery program at Baylor University Medical Center earned its second consecutive 3-Star rating for Isolated CABG from the Society of Thoracic Surgeons. These ratings apply to quality data from January 1, 2018 - June 30, 2019, and it is an honor to be recognized for our award-winning care on the Baylor Scott & White - Dallas campus.


Baylor Scott & White Heart and Vascular Hospital attends annual STEM Goes Red conference

Baylor Scott & White Heart and Vascular Hospital – Dallas and Fort Worth participated in American Heart Association's third annual STEM Goes Red Conference. 150 8th grade students in the Dallas and Irving ISD, as well as students in Fort Worth, attended this all-day workshop and learned about the heart from hospital leaders. The students will be visiting the hospitals at the end of January as part of the program.


TCAR Performed in Fort Worth: First in the area

Mujtaba Ali, MD, on the medical staff in Fort Worth, performed the first ever TCAR procedure on the Fort Worth campus! The procedure occurred in early October. TCAR is short for Transcarotid Artery Revascularization. It combines the safety and reliability of open carotid endarterectomy with the minimally invasive features of carotid stenting. This is a relatively new procedure not performed in many places nationwide.

Often performed under local anesthesia, a small incision is made just above a patient’s collarbone to expose the common carotid artery in the TCAR procedure. Then a soft, flexible sheath is placed directly into the carotid artery, connected to a specialized system to reverse the flow of blood away from the brain to protect against fragments of plaque that may come loose during the procedure. The blood is filtered and returned through a second sheath placed in the femoral vein in the patient’s thigh, and then the stent — a small wire mesh coil —is inserted and placed to open the artery. On the Dallas campus, Dr. Grimsley is the TCAR vascular surgeon.

Adding this procedure to the Baylor Scott & White Heart and Vascular Hospital – Fort Worth portfolio of minimally or less invasive procedures continues to advance cardiovascular care on the Fort Worth campus.


Advantages and new applications of cardiac MRI

Haojie Wang, M.D., director of advanced cardiovascular MRI at Baylor Scott & White Heart and Vascular Hospital - Dallas, discusses new diagnostic imaging and therapy directions for cardiovascular magnetic resonance in Diagnostic and Interventional Cardiology. Baylor Scott & White Heart and Vascular - Dallas is equipped with a dedicated cardiac 1.5 Tesla MRI scanner offering soft tissue visualization not available on CT or ultrasound.

Read more


Scroll To Top